RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)

NCT00830895 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

DRUG: RAD001

Sponsor

Seoul National University Hospital